In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.

Eighty-four children suffering from acute otitis media caused by Streptococcus pneumoniae were treated prospectively with cefuroxime axetil suspension (30 mg/kg of body weight twice daily for 8 days). The high incidence of isolates with decreased susceptibilities to penicillin (42 of 84 isolates) allowed us to establish a relationship between clinical success and the penicillin MICs for pneumococcal isolates. It was found that cefuroxime axetil is clinically effective in the treatment of acute otitis media caused by penicillin-susceptible and penicillin-intermediate strains of S. pneumoniae. The results indicate that the risk of treatment failure with cefuroxime axetil was increased in children with otitis media caused by S. pneumoniae when the penicillin MIC were greater than or equal to 2 mg/liter.
AuthorsP Gehanno, G Lenoir, P Berche
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 39 Issue 1 Pg. 271-2 (Jan 1995) ISSN: 0066-4804 [Print] UNITED STATES
PMID7695322 (Publication Type: Journal Article)
Chemical References
  • Prodrugs
  • cefuroxime axetil
  • Cefuroxime
  • Acute Disease
  • Cefuroxime (analogs & derivatives, therapeutic use)
  • Child, Preschool
  • Humans
  • Infant
  • Microbial Sensitivity Tests
  • Otitis Media (drug therapy, microbiology)
  • Penicillin Resistance
  • Pneumococcal Infections (drug therapy)
  • Prodrugs (therapeutic use)
  • Prospective Studies
  • Streptococcus pneumoniae (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: